Search Results - "Sasamata, M"

Refine Results
  1. 1

    Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs by Iwasa, T, Okamoto, I, Takezawa, K, Yamanaka, K, Nakahara, T, Kita, A, Koutoku, H, Sasamata, M, Hatashita, E, Yamada, Y, Kuwata, K, Fukuoka, M, Nakagawa, K

    Published in British journal of cancer (29-06-2010)
    “…Background: Survivin, a member of the inhibitor of apoptosis protein family, is an attractive target for cancer therapy. We have now investigated the effects…”
    Get full text
    Journal Article
  2. 2

    Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family by Endres, M, Namura, S, Shimizu-Sasamata, M, Waeber, C, Zhang, L, Gómez-Isla, T, Hyman, B T, Moskowitz, M A

    “…Inhibitors of apoptosis and of excitotoxic cell death reduce brain damage after transient and permanent middle cerebral artery occlusion. We compared the…”
    Get more information
    Journal Article
  3. 3

    Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers by Kakuta, H, Sudoh, K, Sasamata, M, Yamagishi, S

    “…There is a growing body of evidence that the renin-angiotensin system (RAS) plays a pivotal role in the pathogenesis of cardiovascular diseases. Indeed, large…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Pharmacological profile of ramosetron, a novel therapeutic agent for IBS by Hirata, T, Funatsu, T, Keto, Y, Nakata, M, Sasamata, M

    Published in Inflammopharmacology (01-02-2007)
    “…Ramosetron is a potent and selective serotonin (5-HT)(3) receptor antagonist that has been shown to affect abnormal colonic function and abdominal pain in…”
    Get full text
    Journal Article
  6. 6

    Real-time blood-pool images of contrast enhanced ultrasound with definity in the detection of tumour nodules in the liver by MARUYAMA, H, MATSUTANI, S, SAISHO, H, MINE, Y, KAMIYAMA, N, HIRATA, T, SASAMATA, M

    Published in British journal of radiology (01-06-2005)
    “…Lower mechanical index (MI) technique with newer microbubble agents has been introduced into clinical practice as a newer ultrasound (US) imaging. However, the…”
    Get full text
    Journal Article
  7. 7

    Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo by Kano, T, Shimizu-Sasamata, M, Huang, P.L, Moskowitz, M.A, Lo, E.H

    Published in Neuroscience (01-10-1998)
    “…Nitric oxide serves as a diffusible messenger within the neuronal networks of the brain. Recent studies have suggested that nitric oxide may amplify…”
    Get full text
    Journal Article
  8. 8

    Novel AMPA Receptor Antagonists:  Synthesis and Structure−Activity Relationships of 1-Hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and Related Compounds by Ohmori, Junya, Shimizu-Sasamata, Masao, Okada, Masamichi, Sakamoto, Shuichi

    Published in Journal of medicinal chemistry (27-09-1996)
    “…As part of our study of novel antagonists at the α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) subtype of excitatory amino acid (EAA) receptors and…”
    Get full text
    Journal Article
  9. 9

    Post-stroke atorvastatin treatment reduces neurological deficits and mortality rate in the stroke-prone spontaneously hypertensive rat by Hayashi, Aska, Suzuki, Masanori, Ogawa, Yumiko, Sonoda, Rie, Sasamata, Masao

    Published in Journal of pharmacy and pharmacology (01-07-2004)
    “…Several large clinical trials have demonstrated that 3‐hydroxy‐3‐methylglutaryl (HMG)‐CoA reductase inhibitors decreased the incidence of stroke independently…”
    Get full text
    Journal Article
  10. 10

    Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats by Yatsugi, S, Takahashi, M, Kawasaki-Yatsugi, S, Koshiya, K, Sakamoto, S, Uematsu, D, Shimizu-Sasamata, M

    “…We studied the effect of a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate antagonist, YM90K [6-(1H-imidazol-1-yl)-7-nitro-2,…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Attenuated Neurotransmitter Release and Spreading Depression-Like Depolarizations after Focal Ischemia in Mutant Mice with Disrupted Type I Nitric Oxide Synthase Gene by Shimizu-Sasamata, Masao, Bosque-Hamilton, Prince, Huang, Paul L, Moskowitz, Michael A, Lo, Eng H

    Published in The Journal of neuroscience (15-11-1998)
    “…Nitric oxide (NO) plays a complex role in the pathophysiology of cerebral ischemia. In this study, mutant mice with disrupted type I (neuronal) NO synthase…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Inhibition of Interleukin 1β Converting Enzyme Family Proteases Reduces Ischemic and Excitotoxic Neuronal Damage by Hara, Hideaki, Friedlander, Robert M., Gagliardini, Valeria, Ayata, Cenk, Fink, Klaus, Huang, Zhihong, Shimizu-Sasamata, Masao, Yuan, Junying, Moskowitz, Michael A.

    “…The interleukin 1β converting enzyme (ICE) family plays a pivotal role in programmed cell death and has been implicated in stroke and neurodegenerative…”
    Get full text
    Journal Article
  18. 18

    In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats by OHTAKE, Akiyoshi, UKAI, Masashi, HATANAKA, Toshiki, KOBAYASHI, Seiji, IKEDA, Ken, SATO, Shuichi, MIYATA, Keiji, SASAMATA, Masao

    Published in European journal of pharmacology (25-05-2004)
    “…Solifenacin succinate [YM905; (+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate] is a new muscarinic receptor…”
    Get full text
    Journal Article
  19. 19

    Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the α1A subunit of P/Q type calcium channels by Ayata, C., Shimizu-Sasamata, M., Lo, E.H., Noebels, J.L., Moskowitz, M.A.

    Published in Neuroscience (01-12-1999)
    “…The P/Q type voltage-gated Ca 2+ channels are involved in membrane excitability and Ca 2+-dependent neurotransmitter release within the CNS. Mutations in the…”
    Get full text
    Journal Article
  20. 20

    Agonist diversity in 5-HT2c receptor-mediated weight control in rats by HAYASHI, Aska, SUZUKI, Masanori, SASAMATA, Masao, MIYATA, Keiji

    Published in Psychopharmacologia (01-03-2005)
    “…Food intake and energy expenditure are the two main determinants of body weight. Given that 5-HT(2C) receptor agonists are reported to have effects on both…”
    Get full text
    Journal Article